SEB Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$184M Sell
705,075
-133,248
-16% -$34.2M 0.68% 24
2026
Q2
$211M Sell
838,323
-108,003
-11% -$23.2M 0.79% 21
2026
Q1
$206M Buy
+946,326
New +$210M 0.88% 17

Other funds holding ABBV

SEB Asset Management's ABBV Position: Q3 2026 in Review

SEB Asset Management reduced its AbbVie (ABBV) stake by 16% in Q3 2026, selling an estimated $34.2M and leaving 705,075 shares worth $184M. The position accounts for 0.68% of the portfolio, ranked #24.

SEB Asset Management first reported a position in ABBV in Q1 2026 and has held it in 3 quarters since. The position peaked at $211M in Q2 2026. 3,830 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • SEB Asset Management held 705,075 shares of AbbVie worth $184M as of Q3 2026.
  • SEB Asset Management sold 133,248 AbbVie shares in Q3 2026, an estimated $34.2M.
  • AbbVie made up 0.68% of SEB Asset Management's portfolio in Q3 2026, its #24 holding.
  • SEB Asset Management first reported a position in AbbVie in Q1 2026 and has held it in 3 quarters since.
  • SEB Asset Management's AbbVie position peaked at $211M in Q2 2026.
  • 3,830 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on SEB Asset Management's 13F filing for Q3 2026, filed 4 Nov 2026.